Tech Company Financing Transactions
VLST Funding Round
Private investors participated in a $5 million capital raise for VLST. The financing round was announced by the company on 6/15/2012.
Transaction Overview
Company Name
Announced On
6/15/2012
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
307 Westlake Ave. North 300
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Overview
VLST Corporation is a privately held biotechnology company that has developed a novel and streamlined approach to speed the development of effective therapeutics for the treatment of inflammatory and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Simonetti
Chief Scientific Officer
Teresa Foy
VP - Bus. Development
Ron Myers
VP - Finance
Brian Blackman
Browse more venture capital transactions:
Prev: 6/15/2012: Cygilant venture capital transaction
Next: 6/15/2012: Regaalo venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs